Quick Comparison

MadecassosideNiacinamide
Typical ConcentrationConcentrations: 0.01-1% as an isolated compound. Products with pure madecassoside are common in K-beauty and French pharmacy brands (La Roche-Posay Cicaplast). Apply morning and night. Excellent as a recovery treatment post-retinoid or post-procedure.Concentrations: 2-10%. 5% is the most studied concentration and provides the best balance of efficacy and tolerability. Higher concentrations (10%) are available but may cause irritation in sensitive skin without proportional benefit. Apply morning and/or night.
ApplicationTopical (serum, cream, balm). Apply to clean skin. Compatible with all active ingredients.Topical (serum, moisturizer, toner). Water-soluble. Stable in formulation. Compatible with most actives.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Madecassoside

Madecassoside (triterpene glycoside from Centella asiatica) inhibits NF-kappa B nuclear translocation by preventing I-kappa B alpha degradation, suppressing transcription of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and COX-2. Activates Nrf2, upregulating antioxidant enzymes (heme oxygenase-1, NQO1, glutathione peroxidase). Stimulates collagen type I synthesis through TGF-beta/Smad3 signaling in fibroblasts, upregulating COL1A1. Promotes keratinocyte migration (wound closure) by enhancing integrin expression and matrix metalloproteinase activity. Inhibits hyaluronidase, preserving skin hyaluronic acid. Reduces VEGF expression, inhibits MMP-1. Comprehensive: anti-inflammatory, antioxidant, pro-collagen, wound-healing. Used in pharmaceutical wound care (Madecassol) and K-beauty. Ideal for post-procedure recovery, retinoid irritation, sensitive skin.

Niacinamide

Niacinamide is converted to NAD+ via the Preiss-Handler pathway—essential for cellular respiration, DNA repair (PARP), and sirtuin regulation. In keratinocytes, it upregulates serine palmitoyltransferase and fatty acid elongases, increasing ceramide synthesis and strengthening the barrier. It inhibits melanosome transfer by downregulating protease-activated receptor-2 (PAR-2) on keratinocytes—brightening without tyrosinase inhibition. In sebocytes, it normalizes lipid synthesis and reduces sebum (possibly via AMPK). Niacinamide inhibits NF-kB translocation, suppressing IL-1beta, TNF-alpha, and IL-8. It inhibits phosphodiesterase, increasing cAMP and modulating keratinocyte differentiation. These multi-pathway effects explain broad efficacy across barrier repair, brightening, acne, and anti-aging.

Risks & Safety

Madecassoside

Common

Essentially none — extremely well-tolerated.

Serious

None documented.

Rare

Very rare allergic reaction.

Niacinamide

Common

Very well-tolerated at 2-5%. Flushing/redness at concentrations above 5% in some individuals.

Serious

None documented.

Rare

Contact dermatitis (uncommon). Old advice to avoid combining with vitamin C is largely debunked at product pH levels.

Full Profiles